← Leaderboards
Timothy Anthony Yap
University Of Tx Md Anderson Can Ctr
$1,826,936
Attributed
$1,826,936
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $370.6K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,826,936 · 1
By mechanism
R01$1,826,936 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- John V. Heymach$11,138,593
- Lilie Leming Lin$2,171,805
- Glen Traver Hart$5,258,043
- Michael Davies$11,575,720
- Ferdinandos Skoulidis$4,461,361
Others in their field
Other Emerging Leaders on “Clinical Trials”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,363,765
- Beth Baseler · Leidos Biomedical Research, Inc.$207,964,226
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$177,411,785
Research focus
Clinical TrialsDefectClinical ResearchAdp RibosylationClinically RelevantClinical DevelopmentBlood SpecimenAntitumor ResponseBak ProteinBrca2 GeneAnimal ModelAdenosine Diphosphate RiboseBiological MarkersCancer CellCancer ModelCancer SubtypesBrca1 GeneCd276 GeneCell ModelCellsCharacteristicsChromatinClinical ApplicationDissociation
Grant awards (5)
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors$370,575
R01 · FY2025 · CA · contact PI
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors$352,047
R01 · FY2024 · CA · contact PI
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors$363,164
R01 · FY2023 · CA · contact PI
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors$370,575
R01 · FY2022 · CA · contact PI
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors$370,575
R01 · FY2021 · CA · contact PI